>>> US After Hours Summary: TIVO +14%, WINT +10%, SNPS +8% following e


After Hours Summary: TIVO +14%, WINT +10%, SNPS +8% following earnings/guidance, PGNX +5% and SFLY +3% on S&P600 index addition news... CFMS -39%, MOH -14%, OMCL -10%, HAWK -10%, CAR -7%, SPWR -6%, TRIP -5% following earnings/guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: CSLT +14.3%, TIVO +13.6%, WINT +9.6%, SNPS +7.5%, QUIK +4.2%, CRY +4.1%, NTAP +4%, NMIH +3%, ABX +2.2%, CSCO +2%, GG +2%, SRCL +1.8%,  DENN +1.6%

Companies trading higher in after hours in reaction to news: XTLB +48.4% (continues to surge higher in after hours trade), CVRS +39.3% (Corindus Vascular Robotics announces a distribution agreement w/ a subsidiary of Mitsubishi (MSBHY); includes an initial order for 12 CorPath GRX Systems accompanied by an advance of $2 mln toward the purchase price), HGG +21% (HHGregg confirms plans to explore strategic alternatives), PGNX +5.1% (to join S&P SmallCap 600), RUBI +3.2% (still checking), SFLY +3.1% (to join S&P SmallCap 600), TECK +2.5% (to sell its 70% interest in Haib Minerals to Deep-South Resources), VRX +1.8% (FDA approves Siliq to treat adults with moderate-to-severe plaque psoriasis), FL +1.3% (light volume; increases quarterly dividend and approves a new 3-year $1.2 bln share repurchase program)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: CFMS -38.6%, MOH -14%, OMCL -9.8%, HAWK -9.6%, CAR -6.6%, SPWR -6.2%, TRIP -5.2%, CLD -4.6% (also replaces its throughput agreement with Westshore Terminals Limited Partnership), GDDY -4.6%, CF -4.3%, MMLP -4% (prices previously announced public offering of 2,600,000 of common units at a price to the public of $18.00 per unit), LSCC -2.8%, EQIX -2.8%, AEM -2.4%, HOS -2.2%, CC -2.1%, KHC -2%, CYS -1.8%, CBS -1.5%

Companies trading lower in after hours in reaction to news: ACUR -29.5% (to be delisted from the Nasdaq; will begin to trade on the OTCQB on February 23), CRSP -6.3% (CRISPR Therapeutics to host call to provide update on the CRISPR/Cas9 U.S. patent interference proceedings and corresponding U.K. patents tomorrow February 16 at 11am ET), NGL -6.2% (commences an underwritten public offering of 8,000,000 common units; intends to offer $450 mln in aggregate principal amount of senior notes due 2025), NAK -3.5% (ongoing volatility), ATKR -2.4% (commences 8 mln common stock offering by selling stockholder), CNC -2.3% (MOH earnings/guidance sympathy), EVOK -2.1% (intends to offer and sell shares of its common stock in a 'firm commitment' underwritten public offering), HTZ -1.6% (CAR sympathy), TRU -1.2% (commences 19.85 mln common stock offering by Selling Stockholders), FRSH -0.9% (announces a strategic realignment of resources aimed at better supporting franchise-owners and field staff while reducing overall SG&A expenses; expects to achieve annual cost savings of $1.5 mln), HOLX 0% (FDA has granted PMA approval for its HCV assay for quantitation of HCV viral load and confirming active HCV infection on the fully automated Panther system)

SunPower earnings weakness is weighing on solar namesVSLR -1.5%, FSLR -1.2%, JKS -0.5%, CSIQ -0.4%